Correlation of international prostate symptom score and uroflowmetry in evaluation of benign prostatic hyperplasia

Anilkumar B. Ugraiah, Sharvari Shyam


Background: Uroflowmetry is a simple non-invasive technique in evaluating patients presenting with Lower urinary tract symptoms (LUTS), to assess voiding patterns, maximum urinary flow (Qmax), average urinary flow (Qave) and voided urine volume. Uroflowmetry is considered mandatory prior to surgical intervention in diagnosis and assessment of men with LUTS. Correlating the International prostrate symptom score (IPSS) with that of uroflowmetry results will allow a better diagnosis and help in determining more appropriate modality of treatment. Therefore, the purpose of our study is to correlate IPSS and the findings of uroflowmetry in evaluation of Benign prostrate hypertrophy (BPH).

Methods: This was a prospective study of 50 patients presenting with LUTS diagnosed with BPH. Patient’s symptoms were initially evaluated by administering a pre-treatment IPSS/Quality of Life Score (QoL) and uroflowmetry. All patients underwent Transurethral resection of the prostate (TURP). A post TURP IPSS/QoL score assessment and uroflowmetry was done. Pre-operative IPSS and uroflowmetry results were correlated using spearman’s correlation coefficient. Outcome of IPSS and uroflowmetry following TURP was assessed in terms of percentage improvement.

Results: Statistically significant correlation (p<0.05) was seen between IPSS and uroflowmetry results. No correlation was found between prostate volume and IPSS. Significant improvement in symptom severity (IPSS score) and uroflowmetry results was observed in post TURP patients.

Conclusion: IPSS is a valuable tool in the evaluation and grading of LUTS. Correlating both IPSS and uroflowmetry results will help in better diagnosis and management of patients. It can also be concluded that IPSS and uroflowmetry can be used for evaluation and monitoring patients following prostate surgery.



Benign prostatic hyperplasia, Lower urinary tract symptoms, Uroflowmetry, International prostate symptom score, Transurethral resection of prostate

Full Text:



Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet. 1991;338:469-71.

Caine M. The present role of alpha-adrenergic blockers in the treatment of benign prostatic hypertrophy. 1986;1361-4.

Coffey DS, Walsh PC. Clinical and experimental studies of benign prostatic hyperplasia. Urol Coin North. 1990;17:461-75.

Peters CA, Walsh PC. The effect of Nafarelin acetate, a luteinizing hormone releasing hormone agonist, on benign prostatic hyperplasia. N. Engl J Med. 1987;317:599-604.

Barry MJ, Fowler FJ, O'leary MP. The American Urological Association Symptom Index for benign prostatic hyperplasia. Journal of Urology. 1992;148:1549-57.

Barry Mi, Fowler FJ Jr, O’Leary MP. The AUA Measurement Committee: Correlation of the American Urological Association Symptom Index with self- administered versions of the Madsen-Iverson, Boyarsky and Maine Medical Assessment Program Symptom indexes. J Urol. 1992;148:1558-63.

Kaplan, Abrams. Evaluation and non-surgical management of BPH. Campbell Walsh Urology. 10th edition. 2012;2611-54.

Rosette JDL, Alivizatos G, Madersbacher S, Sanz CR, Nordling J, Emberton M. European Association of Urology Guidelines on BPH. Smith’s Textbook of Endourology 3rd edition. 2002;2:1453-1455.

Singla S, Garg R, Singla A, Sharma S, Sethi JSP. Experience With Uroflowmetry In Evaluation Of Lower Urinary Tract Symptoms, J Clin Diagn Res. 2014;8(4):N01-03.

Hulley SB, Cummings SR, Browner WS, Grady D, Newman TB. Designing clinical research: an epidemiologic approach. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins. 2013;6C:79.

Halpern EJ. Measurement of the prostate gland. In: McGahan J, Goldberg BB (eds). Atlas of Ultrasound Measurements. 2nd ed. Chicago, IL: Mosby Year Book; 2005.

Aguirre. Evaluation and comparison of prostate volume with open prostatectomy surgical specimen. J. Urol. 1980;86:675-79.

Holtgrewe HL, Mebust WK, Dowd JB. Transurethral prostatectomy: Practice aspects of the dominant operation in American Urology. Urol. 1989;141:248-53.

Vesely S, Knutson T, Damber JE. Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms. J Urol Nephrol. 2003;37:322-8.

Dicuio M, Pomara G, Vesely S. The use of prostatic intravesical protrusion correlated with uroflowmetry: a new method to measure obstruction in patients with LUTS due to BOO without using P/F studies. Arch Ital Urol Androl. 2005;77:50-3.

Ezz el Din K, Kiemeney LA, de Wildt MJ, Debruyne FM, de la Rosette JJ. Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the International Prostate Symptom Score. Urology. 1996;48(3):393-7.

Bosch JLHR, Hop WCJ, Kirkels WJ, Schröder FH. The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. British Journal of Urology. 1995;75:622-30.

Barry MJ, Girman CJ. Using repeated measures of symptom score, uroflowmetry and prostate specific antigen in the clinical management of prostate disease. Benign Prostatic Hyperplasia Treatment Outcomes Study group. J Urol. 1995;153(1):99-103.

Din KEE, Kiemeney LAAM, Wildt MJAM, Debruyne FMJ, Rosette JJMC. Correlation between uroflowmetry, prostate volume, postvoid residual, and lower urinary tract symptoms measured by the International Prostate Symptom Score. Urol. 1996;48:393-7.

Seki N1, Yunoki T, Tomoda T, Takei M, Yamaguchi A, Naito S. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate. Neurourol Urodyn. 2008;27(3):222-5.

Wadie BS, Ibrahim E-HI, de la Rosette JJ, Gomha MA, Ghoneim MA. The relationship of the International Prostate Symptom Score and objective parameters for diagnosing bladder outlet obstruction. Part 1: when statistics fail. J. Urol. 2001;165:32-4.

Bozdar HR, Memon SR, Paryani JP. Outcome of transurethral resection of prostate in clinical benign prostatic hyperplasia. J Ayub Med Coll. 2010;22(4):194.

Harvey MH, Leese T, Lloyd D, Osborn DE. Antibiotic prophylaxis and secondary hemorrhage following transurethral resection of the prostate: a prospective trial. Br Urol. 1986;58:450-2.

Amu OC, Udeh EI, Ugochukwu AI, Dakum NK, Ramyil VM. The value of international prostate symptom scoring system in the management of BPH in Jos, Nigeria. Niger J Clin Pract. 2013;16(3):273-8.

Zhao Z, Wang G, Na YQ. Changes of urinary symptoms after transurethral resection of the prostate and its correlation with clinical parameters. Zhonghua Wai Ke Za Zhi. 2007; 45(14):957-9.

Kallenberg F, Hossack TA, Woo HH. Long-Term Followup after Electrocautery Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia. Advances in Urology. 2011;2011(359478):6.

Chalise PR, Agrawal CS. Changes in urinary symptoms and quality of life in men with benign prostatic hyperplasia after transurethral resection of prostate. Nepal Med Coll J. 2007;9:255-8.

Rahman MH, Islam MA, Joarder AI, Mannan M, Bhuiyan MR, Paul BK. Uroflowmetry before and after transurethral resection of prostate for bladder outlet obstruction. Mymensingh Med J. 2010;19(4):601-7.

Larosa M, Ferretti S, Salsi P, Simonazzi M. Uroflowmetry in the assessment of patients with benign prostatic hyperplasia. Acta Biomed Ateneo Parmense. 1993;64(1-2):17-22.

Nielsen KT, Christensen MM, Madsen PO, Bruskewitz RC. Symptom analysis and uroflowmetry 7 years after transurethral resection of the prostate. J Urol. 1989;142(5):1251-3.

Dorflinger T, England DM, Madsen PO, Bruskewitz RC. Urodynamic and histological correlates of benign prostatic hyperplasia. J Urol. 1988; 140(6):1487-90.

Miah ZI, Bhuiyan ZH. Outcome of 500 cases of transurethral resection of Prostate in District level teaching Hospital. Bangladesh Journal of Medical. 2013;12(2):186-91.